Clinical Trial Update: Effect of AEF0117 on Subjective Effects of Cannabis in CUD Subjects [Phase 2]

View source ↗

Summary

Phase 2 clinical trial evaluating the effect of AEF0117 on subjective effects of cannabis in cannabis use disorder subjects has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Marijuana Use Disorder

Drugs mentioned

• AEF0117

Snippet

Sponsor: Aelis Farma | Conditions: Marijuana Abuse | Phase 2 | Status: COMPLETED